Malignant pleural mesothelioma: current treatments and emerging drugs.
about
Preclinical demonstration of synergistic Active Nutrients/Drug (AND) combination as a potential treatment for malignant pleural mesotheliomaEpigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening.Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy?Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma.Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesotheliomaExpression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo.Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cellsMalignant pleural mesothelioma: current and future perspectivesCurcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis.Revisiting cutaneous adverse reactions to pemetrexedTremelimumab for the treatment of malignant mesothelioma.Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model.Evaluation of imaging techniques for the assessment of tumour progression in an orthotopic rat model of malignant pleural mesothelioma†.Synergistic inhibition of mesothelioma cell growth by the combination of clofarabine and resveratrol involves Nrf2 downregulationBAP1 protein is a progression factor in malignant pleural mesothelioma.Immunotherapy advances for mesothelioma treatment.
P2860
Q28487719-F4562A3F-305C-412B-8C6E-8B5FEC839353Q33985960-161CFEA3-F674-47CA-82DE-867A4D0CEA58Q34339983-C7A97157-C2E8-49E8-8B64-8B0104C03EDFQ34549793-A4449C62-4572-4756-B74D-76417A01E50CQ36159154-C60C69C8-B331-47FB-9072-DC4E6D8110CFQ36200631-FB5CCD5E-7F0B-4DC4-8A23-BCE4F04B8F5BQ36545784-B1838302-717B-46B4-9AF1-F1F392ABEA5AQ36557343-1FE336BA-AB0A-4B0A-B7C3-AD809794FF79Q37217764-25711F1B-920E-45A0-8656-D159516DD97BQ37259632-5169674E-EB27-4509-A5FC-E24638BF0AF1Q38032280-F91A4C67-1E4C-4A01-B862-5D4CC18B2058Q38631254-E7BF22B0-ADBE-4A8C-A898-768CBE1E08A7Q38765125-01FCEE67-D13D-460B-8830-9F3D80F18BB4Q38945140-FE82E6D7-8600-4A05-87F7-05987B9152FCQ42023819-420FE9AD-BCA2-4A26-AF37-32C71D5FBD99Q47734004-DADCC61C-C9E9-4AF4-AE9D-C86C8F940868Q51823843-2D9C34D9-A257-4E40-A42B-91961E8951C3
P2860
Malignant pleural mesothelioma: current treatments and emerging drugs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Malignant pleural mesothelioma: current treatments and emerging drugs.
@en
Malignant pleural mesothelioma: current treatments and emerging drugs.
@nl
type
label
Malignant pleural mesothelioma: current treatments and emerging drugs.
@en
Malignant pleural mesothelioma: current treatments and emerging drugs.
@nl
prefLabel
Malignant pleural mesothelioma: current treatments and emerging drugs.
@en
Malignant pleural mesothelioma: current treatments and emerging drugs.
@nl
P2093
P2860
P1476
Malignant pleural mesothelioma: current treatments and emerging drugs
@en
P2093
Dean Fennell
Giovanni Gaudino
Luciano Mutti
Monica Giovannini
P2860
P304
P356
10.1517/14728210903074563
P407
P50
P577
2009-09-01T00:00:00Z